HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 2.26
Day range
GBX 2.32 - GBX 2.50
Year range
GBX 1.06 - GBX 5.87
Market cap
24.48M GBP
Avg Volume
2.31M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.02M | 129.09% |
Operating expense | 9.14M | -15.21% |
Net income | -5.85M | 43.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | 58.80M | 74.13% |
Total equity | -1.32M | — |
Shares outstanding | 1.03B | — |
Price to book | ∞ | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.85M | 43.43% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | 1.66M | -82.97% |
Net change in cash | -787.50K | -544.92% |
Free cash flow | -4.13M | 34.98% |
About
CEO
Founded
2008
Website
Employees
73
